Empagliflozin is a novel sodium glucose co-transporter-2 (SGLT-2) inhibitor, which is useful for improving glycaemic control in adults with type-2 diabetes mellitus.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
The MOU will involve product collaboration from both companies with a goal of propelling PFAS destruction in groundwater globally
Results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial
Expressed happiness that more than 30 countries of the world have given recognition to Ayurveda as a traditional system of medicine
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
The two-day event focused on the multi-faceted relationship of clinical research stakeholders and looked at bridging the academic and clinical research gap.
Subscribe To Our Newsletter & Stay Updated